| A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids S Ramdas, J Judd, SE Graham, S Kanoni, Y Wang, I Surakka, B Wenz, ... The American Journal of Human Genetics 109 (8), 1366-1387, 2022 | 25 | 2022 |
| A saturated map of common genetic variants associated with human height L Yengo, S Vedantam, E Marouli, J Sidorenko, E Bartell, S Sakaue, ... Nature 610 (7933), 704-712, 2022 | 339 | 2022 |
| ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients A Madrid-Paredes, M Cañadas-Garre, A Sánchez-Pozo, ... Pharmacological research 108, 111-118, 2016 | 14 | 2016 |
| ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis A Madrid-Paredes, M Cañadas-Garre, A Sánchez-Pozo, M Expósito-Ruiz, ... Surgical Oncology 26 (4), 473-482, 2017 | 17 | 2017 |
| Albuminuria-Related Genetic Biomarkers: Replication and Predictive Evaluation in Individuals with and without Diabetes from the UK Biobank M Cañadas-Garre, AT Kunzmann, K Anderson, EP Brennan, R Doyle, ... International Journal of Molecular Sciences 24 (13), 11209, 2023 | | 2023 |
| Association analysis of SNPs on Chromosome Y in renal disease in two cohorts. K Anderson, M Cañadas-Garre, A Maxwell, A McKnight UK Kidney Week 2019, 2019 | | 2019 |
| Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis A Madrid-Paredes, MÁ Casado-Combreras, C Pérez-Ramírez, ... Pathology-Research and Practice 216 (4), 152860, 2020 | 13 | 2020 |
| Author Correction: The power of genetic diversity in genome-wide association studies of lipids SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac, S Ramdas, ... Nature 618 (7965), E19-E20, 2023 | 3 | 2023 |
| Biochemical Biomarkers M Cañadas-Garre, L Smyth, C Neville, K Ryan, A Vijayakumar, F Kee, ... Objective measures of health and wellbeing of older adults in Northern …, 2021 | | 2021 |
| Biomarkers in Diagnosis of Papillary Thyroid Carcinoma M Cañadas-Garre, NM Pérez, JMV del Moral, JAF Orihuela, ... Cancer Biomarkers, 703-774, 2014 | | 2014 |
| BRAF (T1799A) Mutation Is Associated With Papillary Thyroid Carcinomas Larger Than 1 cm M Canadas Garre, E Cabrera Cazorla, P Becerra Massare, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35, S390-S390, 2008 | | 2008 |
| Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer C Perez-Ramirez, M Canadas-Garre, MÁ Molina, AI Robles, ... Mutation Research/Reviews in Mutation Research 771, 32-58, 2017 | 41 | 2017 |
| Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm? N Munoz Perez, JM Villar del Moral, MA Muros Fuentes, ... Langenbeck's Archives of Surgery 398, 709-716, 2013 | 24 | 2013 |
| CP-085 VKORC1 in the selection of oral anticoagulant treatment for atrial fibrillation patients E Jimenez-Varo, M Cañadas-Garre, MAC Hernández European Journal of Hospital Pharmacy: Science and Practice 21 (Suppl 1 …, 2014 | 1 | 2014 |
| CP-116 Biomarkers associated to treatment response and prognosis in Glioblastoma Multiforme J Pérez-Morales, R López-Sepúlveda, M Cañadas-Garre, ... European Journal of Hospital Pharmacy 21 (Suppl 1), A47-A47, 2014 | | 2014 |
| CP-170 Vegfa 2578 C> a as a potential biomarker of survival in patients with HER2 positive breast cancer A Madrid-Paredes, M Cañadas-Garre, M Carrasco, F Artime, M Rodríguez, ... European Journal of Hospital Pharmacy 23 (Suppl 1), A75-A75, 2016 | | 2016 |
| Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer C Perez-Ramirez, A Alnatsha, M Canadas-Garre, E Villar, ... Pharmacogenetics and Genomics 27 (12), 438-444, 2017 | 11 | 2017 |
| De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer A Madrid-Paredes, M Cañadas-Garre, A Sanchez-Pozo, ... Pharmacogenomics 16 (12), 1411-1426, 2015 | 9 | 2015 |
| DI-033 Clinical response of rilotumumab in solid tumours C Pérez-Ramírez, M Cañadas-Garre, FA Rodríguez-Hermida, ... European Journal of Hospital Pharmacy 23 (Suppl 1), A132-A133, 2016 | | 2016 |
| Diabetes-related neurological implications and pharmacogenomics CA Rojas-Carranza, RH Bustos-Cruz, CJ Pino-Pinzón, YV Ariza-Marquez, ... Current pharmaceutical design 24 (15), 1695-1710, 2018 | 54 | 2018 |
